Genus PLC
19 July 2005
FOR IMMEDIATE RELEASE 19 July 2005
GENUS PLC
Issue of Equity to Employee Benefit Trust
Genus plc, the World leading Bovine Genetics Company, announces that application
has been made today for the admission to trading on AIM of 216,700 ordinary
shares of 10p each ('ordinary shares'). The ordinary shares have been issued to
the Genus plc Employee Benefit Trust at nominal value in connection with the
conditional share awards granted on 7 June 2005. These awards have performance
conditions which relate to growth in earnings per share over a three year period
and which trigger vesting on an incremental basis. As previously announced on 8
June 2005, of these share awards, 67,700 and 49,500 were made to Richard Wood,
Chief Executive and to Mr David Timmins, Group Finance Director, respectively.
The new ordinary shares will rank pari passu in all respects with the existing
share capital of the Company.
Trading of the new ordinary shares will commence on 25 July 2005.
For further information please contact:
Genus plc
Edwin White, Chairman of the Remuneration Committee 01256 347100
Bridgewell Ltd
Fred Ward 020 7003 3117
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.